Jennifer L Good - Net Worth and Insider Trading

Jennifer L Good Net Worth

The estimated net worth of Jennifer L Good is at least $791,330 dollars as of 2024-11-05. Jennifer L Good is the President & CEO of Trevi Therapeutics Inc and owns about 213,313 shares of Trevi Therapeutics Inc (TRVI) stock worth over $627,140. Jennifer L Good is also the Director of Rhythm Pharmaceuticals Inc and owns about 3,000 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $164,190. Details can be seen in Jennifer L Good's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer L Good has not made any transactions after 2024-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jennifer L Good

To

Jennifer L Good Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer L Good owns 4 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Trevi Therapeutics Inc (TRVI) , and Juniper Pharmaceuticals Inc (JNP) among others .

Click here to see the complete history of Jennifer L Good’s form 4 insider trades.

Insider Ownership Summary of Jennifer L Good

Ticker Comapny Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2024-09-17 director
TRVI Trevi Therapeutics Inc 2024-09-09 director & 10 percent owner & See Remarks
JNP Juniper Pharmaceuticals Inc 2018-08-14 director
LIMIT LIMIT 2008-10-10 director

Jennifer L Good Latest Holdings Summary

Jennifer L Good currently owns a total of 2 stocks. Among these stocks, Jennifer L Good owns 213,313 shares of Trevi Therapeutics Inc (TRVI) as of September 9, 2024, with a value of $627,140 and a weighting of 79.25%. Jennifer L Good also owns 3,000 shares of Rhythm Pharmaceuticals Inc (RYTM) as of September 17, 2024, with a value of $164,190 and a weighting of 20.75%.

Latest Holdings of Jennifer L Good

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRVI Trevi Therapeutics Inc 2024-09-09 213,313 2.94 627,140
RYTM Rhythm Pharmaceuticals Inc 2024-09-17 3,000 54.73 164,190

Holding Weightings of Jennifer L Good


Jennifer L Good Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer L Good has made a total of 4 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Trevi Therapeutics Inc is the sale of 6,059 shares on September 9, 2024, which brought Jennifer L Good around $18,359.

According to the SEC Form 4 filings, Jennifer L Good has made a total of 3 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 31,751 shares on September 17, 2024, which brought Jennifer L Good around $2 Million.

Insider Trading History of Jennifer L Good

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer L Good Trading Performance

GuruFocus tracks the stock performance after each of Jennifer L Good's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer L Good is -40.12%. GuruFocus also compares Jennifer L Good's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer L Good within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer L Good's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer L Good

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.6 LIMIT LIMIT LIMIT LIMIT LIMIT

Jennifer L Good Ownership Network

Ownership Network List of Jennifer L Good

No Data

Ownership Network Relation of Jennifer L Good

Insider Network Chart

Jennifer L Good Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Jennifer L Good is the director of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Jennifer L Good made 3 insider transaction in Rhythm Pharmaceuticals Inc (RYTM) with a net sale of 83,500. Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 174,805 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 174,805 shares. During the past 18 months, 582,666 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 582,666 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

Jennifer L Good Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer L Good. You might contact Jennifer L Good via mailing address: 15 Great Ring Road, Sandy Hook Ct 06482.